Rimacalib

CAS : 215174-50-8

Ref. 3D-FR177034

Informations sur le produit

• Nom: Rimacalib
• Synonymes: Smp 114

Description

Rimacalib is a non-steroidal anti-inflammatory drug (NSAID) that belongs to the group of drugs known as COX-2 inhibitors. It inhibits the production of prostaglandins, which are inflammatory and pain-producing compounds. Rimacalib is used in the treatment of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. Its clinical use for these diseases is limited by its side effects on the gastrointestinal tract, such as ulcers and bleeding. The most effective dose for Rimacalib is 50 mg twice daily, taken orally with food. This drug binds to the COX-2 receptor in target tissues such as atrial tissue, cardiac tissue, and thp-1 cells. The diameter of these cells was increased following exposure to Rimacalib in cell culture studies. In addition to its anti-inflammatory properties, Rimacalib has been shown to have cardiotoxic effects through cardiac arr

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 394.44 g/mol
• Formule: C₂₂H₂₃FN₄O₂
• Degré de pureté: Min. 95%
• InChI: InChI=1S/C22H23FN4O2/c1-15(17-7-8-18(19(23)13-17)16-5-3-2-4-6-16)20-14-21(29-26-20)25-22(24)27-9-11-28-12-10-27/h2-8,13-15H,9-12H2,1H3,(H2,24,25)/t15-/m0/s1
• Code InChI: InChIKey=MYTIJGWONQOOLC-HNNXBMFYSA-N
• SMILES: C[C@@H](c1ccc(-c2ccccc2)c(F)c1)c1cc(/N=C(\N)N2CCOCC2)on1